UA84351U - USE OF 1-(β-PHENYLETHYL)-4-AMINO-1,2,4-TRIAZOLIUM BROMIDE AS AN ACTIVE BASE OF MEDICINAL AGENTS FOR CORRECTION OF NITROXIDERGIC SYSTEM DYSFUNCTION ON ATHEROSCLEROSIS AND DIABETES MELLITUS - Google Patents

USE OF 1-(β-PHENYLETHYL)-4-AMINO-1,2,4-TRIAZOLIUM BROMIDE AS AN ACTIVE BASE OF MEDICINAL AGENTS FOR CORRECTION OF NITROXIDERGIC SYSTEM DYSFUNCTION ON ATHEROSCLEROSIS AND DIABETES MELLITUS

Info

Publication number
UA84351U
UA84351U UAA201212500U UAA201212500U UA84351U UA 84351 U UA84351 U UA 84351U UA A201212500 U UAA201212500 U UA A201212500U UA A201212500 U UAA201212500 U UA A201212500U UA 84351 U UA84351 U UA 84351U
Authority
UA
Ukraine
Prior art keywords
nitroxidergic
phenylethyl
correction
amino
atherosclerosis
Prior art date
Application number
UAA201212500U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Иван Антонович Мазур
Игорь Федорович Беленичев
Людмила Ивановна Кучеренко
Иван Сергеевич Чекман
Юрий Михайлович Колесник
Андрей Владимирович Абрамов
Нина Викторовна Бухтиярова
Наталья Викторовна Парнюк
Елена Александровна Нагорная
Николай Александрович Авраменко
Юля Антоновна Волчик
Original Assignee
Общество С Ограниченной Ответственностью "Научно-Производственное Объединение "Фарматрон"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Общество С Ограниченной Ответственностью "Научно-Производственное Объединение "Фарматрон" filed Critical Общество С Ограниченной Ответственностью "Научно-Производственное Объединение "Фарматрон"
Priority to UAA201212500U priority Critical patent/UA84351U/en
Publication of UA84351U publication Critical patent/UA84351U/en

Links

Landscapes

  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Use of 1-(phenylethyl)-4-amino-1,2,4-triazolium bromide as active base of medicinal agents for correction of nitroxidergic system dysfunction.
UAA201212500U 2012-11-02 2012-11-02 USE OF 1-(β-PHENYLETHYL)-4-AMINO-1,2,4-TRIAZOLIUM BROMIDE AS AN ACTIVE BASE OF MEDICINAL AGENTS FOR CORRECTION OF NITROXIDERGIC SYSTEM DYSFUNCTION ON ATHEROSCLEROSIS AND DIABETES MELLITUS UA84351U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAA201212500U UA84351U (en) 2012-11-02 2012-11-02 USE OF 1-(β-PHENYLETHYL)-4-AMINO-1,2,4-TRIAZOLIUM BROMIDE AS AN ACTIVE BASE OF MEDICINAL AGENTS FOR CORRECTION OF NITROXIDERGIC SYSTEM DYSFUNCTION ON ATHEROSCLEROSIS AND DIABETES MELLITUS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAA201212500U UA84351U (en) 2012-11-02 2012-11-02 USE OF 1-(β-PHENYLETHYL)-4-AMINO-1,2,4-TRIAZOLIUM BROMIDE AS AN ACTIVE BASE OF MEDICINAL AGENTS FOR CORRECTION OF NITROXIDERGIC SYSTEM DYSFUNCTION ON ATHEROSCLEROSIS AND DIABETES MELLITUS

Publications (1)

Publication Number Publication Date
UA84351U true UA84351U (en) 2013-10-25

Family

ID=52339382

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201212500U UA84351U (en) 2012-11-02 2012-11-02 USE OF 1-(β-PHENYLETHYL)-4-AMINO-1,2,4-TRIAZOLIUM BROMIDE AS AN ACTIVE BASE OF MEDICINAL AGENTS FOR CORRECTION OF NITROXIDERGIC SYSTEM DYSFUNCTION ON ATHEROSCLEROSIS AND DIABETES MELLITUS

Country Status (1)

Country Link
UA (1) UA84351U (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2532394C1 (en) * 2013-10-29 2014-11-10 Общество с ограниченной ответственностью "Научно-производственное объединение "Фарматрон" (НПО "Фарматрон") USING 1-(β-PHENYLETHYL)-4-AMINO-1,2,4-TRIAZOLIUM BROMIDE (HYPERTRIL) AS ACTIVE BASE OF DRUG PREPARATIONS FOR CORRECTING DYSFUNCTIONS OF NITROXYDERGIC SYSTEM OF TARGET ORGANS ACCOMPANYING HOMOCYSTEINEMIA AND ACUTE CEREBROVASCULAR DISORDERS

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2532394C1 (en) * 2013-10-29 2014-11-10 Общество с ограниченной ответственностью "Научно-производственное объединение "Фарматрон" (НПО "Фарматрон") USING 1-(β-PHENYLETHYL)-4-AMINO-1,2,4-TRIAZOLIUM BROMIDE (HYPERTRIL) AS ACTIVE BASE OF DRUG PREPARATIONS FOR CORRECTING DYSFUNCTIONS OF NITROXYDERGIC SYSTEM OF TARGET ORGANS ACCOMPANYING HOMOCYSTEINEMIA AND ACUTE CEREBROVASCULAR DISORDERS

Similar Documents

Publication Publication Date Title
IN2012DN06714A (en)
MX2013015168A (en) Glucagon/glp-1 receptor co-agonists.
MX347703B (en) Glucagon/glp-1 receptor co-agonists.
EP3010892B8 (en) 1,2,4-triazoles as nuclear transport modulators and uses thereof
EP3030493A4 (en) Overlay applicator, applicator machine, and cradle, and method of providing and using the same
EP2556770A4 (en) Desk for maintaining correct posture, and system furniture comprising the desk
MY181898A (en) Heterocyclic compounds and uses thereof
MX2015013154A (en) Use of perfusion decellularized liver for islet cell recellularization.
GEP20186891B (en) Stable preservative-free mydriatic and anti-inflammatory solutions for injection
TW201144301A (en) Processes for preparing linezolid
IN2013DN02552A (en)
EP2763672A4 (en) 1,3-substituted azetidine pde10 inhibitors
EP3030226A4 (en) Delivery system for active agents
EP2773623A4 (en) 1-(arylmethyl)-5,6,7,8-tetrahydroquinazoline-2,4-diones and analogs and the use thereof
EP3083464A4 (en) Overlay applicator, applicator machine, and cradle, and method of providing and using the same
UA114345C2 (en) 6-((s)-1-{1-[5-(2-hydroxy-ethoxy)-pyridin-2-yl]-1h-pyrazol-3-yl}-ethyl)-3h-1,3-benzothiazol-2-one as a tarp-gamma 8 dependent ampa receptor antagonist
WO2015164387A3 (en) Systems, methods, and apparatus for providing machine-to-machine and consumer-to-machine interaction application platforms
GB2480888B (en) Femtocell, communication method for the femtocell, and computer readable medium thereof
UA84351U (en) USE OF 1-(β-PHENYLETHYL)-4-AMINO-1,2,4-TRIAZOLIUM BROMIDE AS AN ACTIVE BASE OF MEDICINAL AGENTS FOR CORRECTION OF NITROXIDERGIC SYSTEM DYSFUNCTION ON ATHEROSCLEROSIS AND DIABETES MELLITUS
MX345263B (en) Stable pexiganan formulation.
MX366768B (en) Orodispersible sildenafil tablet and preparation method thereof.
IT1400702B1 (en) EQUIPMENT FOR PACKING LOADS WITH THERMORETABLE FILM, EQUIPPED WITH ADJUSTABLE BURNERS.
UA80811U (en) ETHYL 3-(3,4-DIMETHYLPHENYL)-6-THIOXO-7-CYANO-1,3,4,6-2H-PYRIDO[1,2-a][1,3,5]TRIAZINE -9-CARBOXYLATE
양만표 Thrombosis
HK1190259A1 (en) Bidirectional communication system, and method for compensating for undesired feedback in the bidirectional communication system